MicroPort NeuroScientific Corp Sustainability Reports
Develops and commercializes medical devices for neurovascular diseases, focusing on hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01841HZS8
4 reports from 2022 to 2025